Maintenance intravenous fluids with 0.9% sodium chloride do not produce hypernatraemia in children

M. Moritz,J. Ayus

DOI: https://doi.org/10.1111/j.1651-2227.2011.02535.x

2012-03-01

Acta Paediatrica

Abstract:The standard of care in paediatrics for over 50 years has been to administer hypotonic intravenous fluids (IVF) to children in need of IVF therapy (1). This recommendation has been largely based on the assumption that the sodium concentration in IVF should reflect that found in the diet of an otherwise healthy child (2). The flaw in this approach is that hospitalized children have numerous stimuli for arginine vasopressin production. The administration of hypotonic IVF, sodium plus potassium concentration of IVF <154 mEq ⁄ L, would predictably result in hyponatraemia from impaired free water excretion (3). In 2003, we pointed out the dangers of the routine administration of hypotonic IVF to hospitalized children as it had been associated with numerous cases of hyponatraemic encephalopathy, many of which resulted in death or permanent neurologic impairment (3,4). We suggested that 0.9% sodium chloride (NaCl), sodium concentration 154 mEq ⁄ L, be used in maintenance IVF with hypotonic IVF being reserved for patients with either hypernatraemia or ongoing urinary or extrarenal free water losses. A major criticism of our approach was the fear that 0.9% NaCl would result in hypernatraemia (5). Since our original recommendation, there have been 18 prospective studies in over 1000 children, demonstrating that hypotonic IVF result in a significant fall in serum sodium whereas 0.9% NaCl helps maintain serum sodium without producing hypernatraemia (6,7). At the time of our initial recommendation, we were careful not to extend our recommendations to the term and preterm neonate because of unique physiologic issues seen in this age group (3). In this issue of Acta Pediatrica, Balasubramanian et al. report on a double-blind, randomized and controlled trial involving term neonates with hyperbilirubinaemia. They compared the effect of 0.2% NaCl vs. 0.9% NaCl administered over 8 h on change in serum sodium (8). They found that 0.2% NaCl resulted in a 45% incidence of hyponatraemia (Na < 135 mEq ⁄ L) at 24 h compared to only 7% with 0.9% NaCl, resulting in an odds ratio of 13 for developing hyponatraemia with 0.2% NaCl. They also observed that the 0.9% NaCl group had a 40% incidence of hypernatraemia (Na > 145 mEq ⁄ L) compared to 12% for the 0.2% NaCl. Based on this, they concluded that 0.9% NaCl may not be appropriate for the term neonate. What the authors failed to appreciate though is that the patients enrolled in this study were hypernatraemic at the time of enrolment. There were no exclusion criteria for abnormal serum sodium, and hypernatraemic patients were included. The average serum sodium at the time of enrolment was 143 ± 6 mEq ⁄ L. The exact number of patients with hypernatraemia at enrolment was not reported, but three patients (7%) in the 0.9% NaCl group had severe hypernatraemia (>150 mEq ⁄ L) at the time of enrolment. In this study, 0.9% NaCl did not produce hypernatraemia but rather perpetuated it where pre-existing; 0.9% NaCl resulted in no real change in serum sodium over the 8 h, with a reported fall in serum sodium for the 0.9% NaCl group of )0.01 mmol ⁄ h; 0.9% NaCl does not produce hypernatraemia when used in the absence of a renal Invited Commentary for Karthik Balasubramanian et al. Isotonic versus hypotonic fluid supplementation in term neonates with severe hyperbilirubinemia – a double-blind, randomized, controlled trial, pages 236–241. Acta Pædiatrica ISSN 0803–5253